Pain
Evidence-Based Reviews
Opioid use disorder in adolescents: An overview
Treatment needs to include interventions that address young patients’ unique needs.
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010
From the Journals
Cannabis for sleep: Short-term benefit, long-term disruption?
“This suggests that while cannabis may improve overall sleep, it’s also possible that there is a tolerance that develops with either very frequent...
Feature
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News from the FDA/CDC
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
Evidence-Based Reviews
Antipsychotics, dopamine, and pain
These medications’ effects on dopamine might help address chronic pain.
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
Conference Coverage
In addiction, abusive partners can wreak havoc
SAN DIEGO – Strategies of abusive partners include sabotaging and discrediting their partners’ attempts at recovery, Dr. Carole Warshaw said.
Conference Coverage
Addiction specialists: Cannabis policies should go up in smoke
SAN DIEGO –
From the Journals
Chronic pain more common in women with ADHD or ASD
Treating patients’ ADHD helps to reduce the pain in some cases, researchers report.
Conference Coverage
Depression linked to persistent opioid use after hysterectomy
VANCOUVER – Women with preoperative depression were more likely to have a comorbid pain disorder, compared with...